Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.50 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.48 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.39 |
| ▸ | UNG | P13051 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.37 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6852409 | 0.79 | ALDH1A1 (0.68) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| SCHEMBL3757660 | 0.79 | ALDH1A1 (0.68) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| SCHEMBL5187908 | 0.78 | ALDH1A1 (0.52) | ALDH1A1ALDH5A1ABATHSD17B10KMT2A | |
| SCHEMBL18133156 | 0.77 | ALDH1A1 (0.65) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| SCHEMBL7191197 | 0.77 | ALDH1A1 (0.58) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| Terephthalic Acid SCHEMBL11068404 | 0.77 | ALDH1A1 (1.00) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| SCHEMBL63361 | 0.77 | ALDH1A1 (1.00) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| SCHEMBL1664743 | 0.77 | ALDH1A1 (0.65) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| SCHEMBL23637785 | 0.76 | ALDH1A1 (0.64) | ALDH1A1ALDH5A1ABATPARP10PARP3 | |
| Bicarbonate SCHEMBL27621047 | 0.75 | ALDH1A1 (0.70) | ALDH1A1ALDH5A1ABATPARP10PARP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4103092-A | Water-soluble quaternary ammonium non-heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1978-07-25 | — | — | US | claimed |
| US-20210188895-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE, AND PRODUCTION METHOD THEREFOR | BONAC CORPORATION (JP) | 2021-06-24 | — | — | US | disclosed |
| EP-3696269-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE, AND PRODUCTION METHOD THEREFOR | Bonac Corporation (JP) | 2020-08-19 | — | — | EP | disclosed |
| US-8071243-B2 | Fuel cell system | PANASONIC CORPORATION (JP) | 2011-12-06 | — | — | US | disclosed |
| US-20090047555-A1 | FUEL CELL SYSTEM | PANASONIC CORPORATION (JP) | 2009-02-19 | — | — | US | disclosed |
| US-4206144-A | N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts | STERLING DRUG INC. (US) | 1980-06-03 | — | — | US | disclosed |
| US-4146558-A | Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group | STERLING DRUG INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4103092-A | Water-soluble quaternary ammonium non-heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4065500-A | Water-soluble quaternary ammonium azo dyestuffs | STERLING DRUG INC. (US) | 1977-12-27 | — | — | US | disclosed |
| US-3996282-A | Water-soluble quaternary ammonium dyestuffs | STERLING DRUG INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3935182-A | Water-soluble quaternary ammonium heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188895-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE, AND PRODUCTION METHOD THEREFOR | POLRMT, POLL, RNGTT | ALDH1A1 1171/4885ALDH5A1 534/4885ABAT 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.